ISPOR Releases Its New Science Strategy

Published Mar 1, 2021

The Multiyear Blueprint Will Guide the Society’s Efforts and Mission-Focused Initiatives

ISPOR Science Strategy - CoverLawrenceville, NJ, USA—March 1, 2021—ISPOR—The Professional Society for Health Economics and Outcomes Research announced today that it has released its Science Strategy—a multiyear blueprint that will guide the Society’s efforts and mission-focused initiatives.

The need has never been greater for health economics and outcomes research (HEOR) to inform healthcare decisions. Healthcare’s myriad challenges—the COVID-19 pandemic, the growth of innovative (but expensive) curative therapies, the move toward universal healthcare, the need to provide optimal health outcomes for patients within budget constraints, to name a few—combined with the increasing complexity of healthcare—bring the demand for HEOR to the forefront.

The objective of the ISPOR Science Strategy is to identify a targeted set of topical “themes” that the Society believes will have the greatest impact on both the field of HEOR and global healthcare and can be leveraged to advance the science, drive innovation in the field, and have an even greater impact on improving healthcare decisions. The Science Strategy was a direct mandate from ISPOR’s Strategic Plan Update 2024. The themes identified and outlined in the Science Strategy report include:

  • Real-World Evidence
  • Economic Evaluation Methods
  • Patient-Centered Research
  • Special Populations and Technologies
  • HTA in Healthcare Decision Making
  • Health Economics, Access, and Policy
  • Low- and Middle-Income Countries
  • Resilient Learning Healthcare Systems

“We are very excited to release our new ISPOR Science Strategy,” stated ISPOR’s Chief Science Officer, Richard J. Willke, PhD. “The development of the Science Strategy was heavily informed by our members. As a member-driven organization, we rely on member input to guide all that we do.”

ISPOR is also presenting its Science Strategy on March 23, 2021 in a webinar that is open to both members and nonmembers. The webinar, “ISPOR's New Science Strategy—A Member-Generated Roadmap of HEOR Priorities and Frontiers,” will be led by ISPOR’s Chief Science Officer Richard J. Willke, PhD and the ISPOR Health Science Policy Council Chair Shelby D. Reed, RPh, PhD.

Additional information on the ISPOR Science Strategy can be found here.

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

ISPOR Launches “About Real-World Evidence” Content

Mar 8, 2022

ISPOR announced that it has launched a new “About Real-World Evidence” microsite. This introductory content is designed for the broader healthcare audience toward the goal of engaging healthcare professionals in advancing best practices for the use of real-world evidence in clinical decision making.

New Real-World Evidence Registry Launches

Oct 26, 2021

ISPOR announced that the Real-World Evidence Transparency Initiative has launched the Real-World Evidence Registry.

ISPOR’s Real-World Evidence Transparency Initiative: Creating a Road Map That Builds Trust

Oct 5, 2020

ISPOR announced the publication of a plan from the Real-World Evidence Transparency Initiative to encourage routine registration of noninterventional real-world evidence studies used to evaluate treatment effects.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×